about
Clinical features of adult patients with acute hepatitis B virus infection progressing to chronic infection.Utility of Contrast-Enhanced Transabdominal Ultrasonography to Diagnose Early Chronic Pancreatitis.Downregulation of ANP32B exerts anti-apoptotic effects in hepatocellular carcinomaDietary intake habits and the prevalence of nocturia in Japanese patients with type 2 diabetes mellitus.A better method for assessment of hepatic function in hepatocellular carcinoma patients treated with radiofrequency ablation: Usefulness of albumin-bilirubin grade.Physical activity and prevalence of erectile dysfunction in Japanese patients with type 2 diabetes mellitus: The Dogo Study.Relative changes in handgrip strength and skeletal muscle volume in patients with chronic liver disease over two-year observation period.Muscle volume loss a prognostic factor for death in liver cirrhosis patients and special relationship to portal hypertension.Quantitative assessment of liver fibrosis reveals a nonlinear association with fibrosis stage in nonalcoholic fatty liver disease.Roles of protein kinase R in cancer: Potential as a therapeutic target.Nonalcoholic fatty liver with a hepatic arterial buffer response strongly associated with future metabolic disease.Predictors of hepatocellular carcinoma occurrence after direct-acting antiviral therapy in patients with HCV infectionEffects of Motilin Receptor Agonists and Ghrelin in Human motilin receptor Transgenic MiceStimulated hepatic stellate cell promotes progression of hepatocellular carcinoma due to protein kinase R activationNovel quantitative assessment system of liver steatosis using a newly developed attenuation measurement methodNeutrophil-to-lymphocyte ratio is associated with survival in patients with unresectable hepatocellular carcinoma treated with lenvatinibAnalysis of 307 cases with drug-induced liver injury between 2010 and 2018 in JapanInsulin-like growth factor-1 is inversely associated with liver fibrotic markers in patients with type 2 diabetes mellitusSafety and efficacy of lenvatinib in elderly patients with unresectable hepatocellular carcinoma: A multicenter analysis with propensity score matchingTherapeutic potential of lenvatinib for unresectable hepatocellular carcinoma in clinical practice: Multicenter analysisZinc deficiency as an independent prognostic factor for patients with early hepatocellular carcinoma due to hepatitis virusPrediction of risk of falls based on handgrip strength in chronic liver disease patients living independentlySARC-F combined with a simple tool for assessment of muscle abnormalities in outpatients with chronic liver diseaseLongitudinal impact of dapagliflozin treatment on ventricular repolarization heterogeneity in patients with type 2 diabetesNew diagnostic technique to evaluate hepatic steatosis using the attenuation coefficient on ultrasound B modeSex difference in the development of hepatocellular carcinoma after direct-acting antiviral therapy in patients with HCV infectionEfficacy of combining electric-field and C-plane imaging to obtain ultrasound-ultrasound fusion images in monopolar radiofrequency ablation for patients with liver cancer
P50
Q34366249-3D213708-E9E7-435B-A63D-5CF81D8ECF00Q35674396-7993252D-22C1-4F71-9BA5-E3E4089E7489Q36367144-D32DA3E1-1DD9-4251-AB76-EA1CCFABD68FQ40138645-CC95112E-C973-491C-B9CA-9BEB00E02E62Q40154217-05B75CAB-54B4-484E-9328-AA8C616232EDQ40260761-3B3C057C-2B7D-4219-B781-86F285923310Q47556384-50BBD1C7-EFDB-449D-97C8-8D6AA72261A2Q48304531-F9EFEE69-CF7F-499A-A26B-5956CCDB38DEQ52699058-4AAC967E-CAC3-47FC-8858-46CA637E6CAAQ53924963-B8D2C4E6-EC7D-4514-A5F8-CB187BFF4D55Q55361713-F87BDD77-20B4-4036-828C-3C8FF516DF1DQ58596840-5924E4F8-66F3-4CB3-ADA0-27164BFBE2A3Q64112541-3285F9C3-1CB3-4ACC-BCF5-54FCF024096CQ64114887-B1016076-2E1A-4C14-91AC-AF6E5D1A6C1FQ88428333-7BC52B3A-4AB2-4947-84CA-2B048639B84DQ89739672-77950935-E4F9-40F9-ACD5-9FF0F3DD7273Q90631296-AE395FC4-C008-4A7B-8454-AA3A7EEC3624Q90791802-E4759E17-4F71-4CED-9B4E-A02061624F2AQ90982789-849A345D-ABDA-458E-B66B-DE81E5F203D0Q91136638-82913C45-110A-4452-B345-3D9DD706D6F2Q91290772-09FD9751-0296-4246-BB34-7CC6B994E02EQ91634861-312F135A-7D37-4981-8BDF-31BDB0D339FBQ91919920-336AD126-156F-461D-84A7-BA22B440D924Q92030988-9235C543-993E-4FD7-9584-0E5C32B79A88Q92900970-54EF444C-CF5B-46FD-97F0-C10B3E4BE2D5Q94568858-91A34DAD-2E57-463C-B1DA-14619335AFB4Q95645738-C6FAED30-8286-4466-9287-8953E005D253
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Yoichi Hiasa
@en
Yoichi Hiasa
@nl
type
label
Yoichi Hiasa
@en
Yoichi Hiasa
@nl
prefLabel
Yoichi Hiasa
@en
Yoichi Hiasa
@nl
P31
P496
0000-0003-4117-339X